Share Public Profile

Public Profile URL

LDNIM

United States

http://ldnim.com

"Low-dose naltrexone (LDN) is a safe, inexpensive, yet underused drug that is extremely beneficial for people with conditions marked by immune system dysfunction."

Show Articles inside

Naltrexone at low doses for cancer summary of trials

January 3, 2018

Everything you need to know about ldn

January 3, 2018

effects of low dose naltrexone on feed intake, growth, endocrine and immune parameters in the recent

January 3, 2018

The use of low dose naltrexone (ldn) as a novel anti inflammatory treatment for chronic pain

August 21, 2016

Bridging study to evaluate the effects of lodonal hiv

July 22, 2016

Is type 2 diabetes a chronic inflammator [diabetes nutr metab 2002] pubmed ncbi

April 13, 2015

Topical naltrexone as treatment for type 2 diabetic cutaneous wounds

April 13, 2015

Selective blockade of the ogf ogfr pathway by naltrexone accelerate pubmed ncbi

April 13, 2015

Antineuropathic effect of 7 hydroxy 3,4 dihydrocadalin in streptozo pubmed ncbi

April 13, 2015

Mclaughlinpj,zagonis 2012 ogf axishealth & disease xps

April 13, 2015

Autoimmune disorders in diabetes [adv nephrol necker hosp 1986] pubmed ncbi

April 13, 2015

Naltrexone and insulin are independently effecti [exp eye res 2009] pubmed ncbi

April 13, 2015

Topical treatment with the opioid antagonist naltrexone accelerates pubmed ncbi

April 13, 2015

B cell lymphoma paper berkson b cell lymphoma paper 2007

April 12, 2015

Multiple sclerosis research low dose naltrexone for treatment of multiple sclerosis are clinical tri

April 12, 2015

Opiod receptors and inflammation 2003

April 12, 2015

Naltrexone for impulse control disorders in parkinson's disease no study results posted clinicaltria

April 12, 2015

Ldn in the treatment of hiv infection biharib september 1996

April 12, 2015

Fibromyalgia, autism, and opioid addiction as natural and induced d pubmed ncbi

April 12, 2015

Berksonbm ldn therapy of metastatic pancreatic cancer 2006

April 12, 2015

Naltrexone as therapy in uc and crohn's disease

April 12, 2015

Ms gironi et al trial 2008

April 12, 2015

Enkephlain elevations contribute to neuronal and behavioral impairments in mouse model

April 12, 2015

Alpha lipoic acid and liver disease (dec 2007) townsend letter for doctors & patients

April 12, 2015

Ldn in the treatment of hiv infection biharib september 1996

April 12, 2015

The role of opiates in ibs

April 12, 2015

Neuroblasoma in nude mice mclaughln jp, zagon is xps

April 12, 2015

Longterm remission of adenoid cystic tongue carcinoma with low dose naltrexone and vitamin d a case

April 12, 2015

Pediatric fda orphan drug protocol 22jan2011

April 12, 2015

Ldn treatment of acquired immune deficiency syndrome 1988 biharib

April 12, 2015

Impact of ldn for the treatmetn of hiv aids ii malawi

April 12, 2015

Dr smithjp ldn & crohn's disease 2007 1

April 12, 2015

Efficacy and safety of naltrexone use in pediatric patients with au pubmed ncbi

April 12, 2015

Crohn’s study results 29 treatments rated by patients

April 12, 2015

Depression in crohn's disease miller ah et al,2012

April 12, 2015

Menk levels in inflam bowel disease

April 12, 2015

Ms placebo controlled trial sharafaddinzadeh et al 2010

April 12, 2015

Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model

April 12, 2015

Low dose naltrexone for treatment of duode [inflamm bowel dis 2010] pubmed ncbi

April 12, 2015

Autism effects of 20mgn double blind study

April 12, 2015

Ldn in the treatment of austism

April 12, 2015

Zagon i opioids in human & animal cancer jnci 1987 xps

April 12, 2015

Zagonis et al ogf r in human cancers 2009 xps

April 12, 2015

Ldn synopsis use of ldn in asd and other illnesses tb ref

April 12, 2015

Alpha lipoic acid berkson

April 12, 2015

Als naltrexone

April 12, 2015

Fibromyalgiaprocamcontrolconf pmc 2011

April 12, 2015

Premature immunosenescence in rheumatoid ar[ann n y acad sci 2005] pubmed ncbi

April 12, 2015